Dynorphin B Creates a Self-Amplifying Loop in Diseased Heart Cells
Dynorphin B stimulates its own gene expression in cardiac myocytes through an autocrine feedback loop, which is dramatically amplified in cardiomyopathic hearts.
Quick Facts
What This Study Found
Dynorphin B induces dose-dependent autocrine stimulation of its own gene expression in cardiac myocytes, creating a self-amplifying loop that is exaggerated in cardiomyopathy.
Key Numbers
How They Did This
In vitro study using normal and cardiomyopathic hamster cardiac myocytes. Exogenous dynorphin B was added and prodynorphin mRNA levels and gene transcription were measured.
Why This Research Matters
An autocrine opioid peptide amplification loop in the heart could represent a therapeutic target for treating cardiomyopathy by breaking the self-reinforcing cycle.
The Bigger Picture
This finding revealed a novel pathological mechanism where opioid peptides contribute to heart disease progression through self-amplifying feedback, offering a potential drug target.
What This Study Doesn't Tell Us
In vitro hamster cardiomyocyte study. The specific cardiomyopathy model (BIO 14.6) may not represent all human cardiomyopathies.
Questions This Raises
- ?Could blocking the dynorphin autocrine loop slow cardiomyopathy progression?
- ?Is this autocrine mechanism present in human cardiomyopathy?
Trust & Context
- Key Stat:
- Self-amplifying opioid loop Dynorphin B stimulates its own gene expression in heart cells, creating a dose-dependent autocrine feedback loop amplified in disease
- Evidence Grade:
- Moderate in vitro evidence from a hereditary cardiomyopathy model with clear dose-dependent autocrine effects.
- Study Age:
- Published in 1997, revealing a novel pathological mechanism of cardiac opioid peptide signaling.
- Original Title:
- Opioid peptide gene expression in the primary hereditary cardiomyopathy of the Syrian hamster. III. Autocrine stimulation of prodynorphin gene expression by dynorphin B.
- Published In:
- The Journal of biological chemistry, 272(10), 6699-705 (1997)
- Authors:
- Ventura, C(3), Pintus, G(2)
- Database ID:
- RPEP-00438
Evidence Hierarchy
Frequently Asked Questions
What is an autocrine loop?
Autocrine signaling is when a cell produces a substance that then acts back on the same cell to stimulate more production of that substance. It's a self-amplifying cycle that can spiral out of control in disease.
Why does this matter for heart disease?
In cardiomyopathy, dynorphin B production increases dramatically. This study shows the peptide stimulates its own further production, creating a vicious cycle. Breaking this cycle could be a new way to treat the disease.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00438APA
Ventura, C; Pintus, G. (1997). Opioid peptide gene expression in the primary hereditary cardiomyopathy of the Syrian hamster. III. Autocrine stimulation of prodynorphin gene expression by dynorphin B.. The Journal of biological chemistry, 272(10), 6699-705.
MLA
Ventura, C, et al. "Opioid peptide gene expression in the primary hereditary cardiomyopathy of the Syrian hamster. III. Autocrine stimulation of prodynorphin gene expression by dynorphin B.." The Journal of biological chemistry, 1997.
RethinkPeptides
RethinkPeptides Research Database. "Opioid peptide gene expression in the primary hereditary car..." RPEP-00438. Retrieved from https://rethinkpeptides.com/research/ventura-1997-opioid-peptide-gene-expression
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.